U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 385

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr4:178363527
GRCh38:
Chr4:177442373
AGAM1IAspartylglucosaminuriaLikely pathogenic
(May 4, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr4:178363491
GRCh38:
Chr4:177442337
AGAL15fsAspartylglucosaminuriaLikely pathogenic
(Apr 14, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr4:178363478
GRCh38:
Chr4:177442324
AGA-DT, AGAQ18*AspartylglucosaminuriaPathogenic
(Feb 23, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr4:178352870
GRCh38:
Chr4:177431716
AGAC335R, C345RAspartylglucosaminuriaUncertain significance
(May 22, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr4:178358675
GRCh38:
Chr4:177437521
AGAAspartylglucosaminuriaLikely pathogenic
(Jan 31, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr4:178352862-178363529
AGAAspartylglucosaminuriaUncertain significance
(Jan 28, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr4:178351918-178357515
AGAAspartylglucosaminuriaPathogenic
(Feb 22, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr4:178357420-178363667
AGAAspartylglucosaminuriaPathogenic
(Aug 6, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr4:178361543
GRCh38:
Chr4:177440389
AGAAspartylglucosaminuriaLikely benign
(Mar 10, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr4:178360859
GRCh38:
Chr4:177439705
AGAAspartylglucosaminuriaLikely benign
(Mar 12, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr4:178360813
GRCh38:
Chr4:177439659
AGAD104VAspartylglucosaminuriaUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr4:178360017
GRCh38:
Chr4:177438863
AGAAspartylglucosaminuriaLikely benign
(Aug 9, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr4:178363449
GRCh38:
Chr4:177442295
AGAAspartylglucosaminuriaLikely benign
(Sep 19, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr4:178352903
GRCh38:
Chr4:177431749
AGAE324*, E334*AspartylglucosaminuriaUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr4:178355579
GRCh38:
Chr4:177434425
AGAA245T, A255TAspartylglucosaminuria, Inborn genetic diseasesUncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr4:178358636
GRCh38:
Chr4:177437482
AGAY182CAspartylglucosaminuriaUncertain significance
(Jul 18, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr4:178358624
GRCh38:
Chr4:177437470
AGAG186AAspartylglucosaminuriaUncertain significance
(Sep 14, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr4:178358561
GRCh38:
Chr4:177437407
AGAI207TAspartylglucosaminuriaUncertain significance
(Jul 29, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr4:178357515-178357516
GRCh38:
Chr4:177436361-177436362
AGAAspartylglucosaminuriaBenign
(May 14, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr4:178354369-178354370
GRCh38:
Chr4:177433215-177433216
AGAY313*, Y303*AspartylglucosaminuriaUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr4:178359978
GRCh38:
Chr4:177438824
AGAN143SAspartylglucosaminuria, Inborn genetic diseasesUncertain significance
(Aug 5, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr4:178354499
GRCh38:
Chr4:177433345
AGAY260C, Y270CAspartylglucosaminuriaUncertain significance
(Mar 28, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr4:178352895-178352896
GRCh38:
Chr4:177431741-177431742
AGAN336fs, N326fsAspartylglucosaminuriaUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr4:178360784
GRCh38:
Chr4:177439630
AGAV114MAspartylglucosaminuriaUncertain significance
(Apr 7, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr4:178360812
GRCh38:
Chr4:177439658
AGAD104EAspartylglucosaminuriaUncertain significance
(May 28, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr4:178363516
GRCh38:
Chr4:177442362
AGA-DT, AGAS5LAspartylglucosaminuriaUncertain significance
(Aug 12, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr4:178354394
GRCh38:
Chr4:177433240
AGAI295K, I305KAspartylglucosaminuriaUncertain significance
(Jul 17, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr4:178354393
GRCh38:
Chr4:177433239
AGAI295M, I305MAspartylglucosaminuriaUncertain significance
(May 31, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr4:178360854
GRCh38:
Chr4:177439700
AGAAspartylglucosaminuriaLikely benign
(Oct 1, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr4:178352903
GRCh38:
Chr4:177431749
AGAE324K, E334KAspartylglucosaminuriaUncertain significance
(Apr 22, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr4:178361416
GRCh38:
Chr4:177440262
AGAAspartylglucosaminuriaLikely benign
(May 9, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr4:178360015
GRCh38:
Chr4:177438861
AGAAspartylglucosaminuriaLikely benign
(Mar 8, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr4:178363454
GRCh38:
Chr4:177442300
AGA, AGA-DTP26SAspartylglucosaminuriaUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr4:178355516
GRCh38:
Chr4:177434362
AGAAspartylglucosaminuriaLikely benign
(Feb 28, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr4:178355642
GRCh38:
Chr4:177434488
AGAR234CAspartylglucosaminuriaUncertain significance
(Jun 12, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr4:178354394
GRCh38:
Chr4:177433240
AGAI295R, I305RAspartylglucosaminuriaUncertain significance
(Jul 30, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr4:178355524
GRCh38:
Chr4:177434370
AGAAspartylglucosaminuriaLikely benign
(Sep 26, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr4:178355522-178355523
GRCh38:
Chr4:177434368-177434369
AGAAspartylglucosaminuriaLikely benign
(Sep 26, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr4:178355597
GRCh38:
Chr4:177434443
AGAD249N, D239NAspartylglucosaminuriaUncertain significance
(Jun 18, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr4:178354369
GRCh38:
Chr4:177433215
AGAAspartylglucosaminuriaUncertain significance
(Aug 12, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr4:178361492
GRCh38:
Chr4:177440338
AGAAspartylglucosaminuriaLikely benign
(Apr 24, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr4:178359995
GRCh38:
Chr4:177438841
AGAAspartylglucosaminuriaLikely benign
(Jun 8, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr4:178361478
GRCh38:
Chr4:177440324
AGAG77EAspartylglucosaminuriaUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr4:178359917
GRCh38:
Chr4:177438763
AGAAspartylglucosaminuriaLikely benign
(Apr 15, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr4:178360832
GRCh38:
Chr4:177439678
AGAD98YAspartylglucosaminuriaUncertain significance
(Aug 18, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr4:178355529
GRCh38:
Chr4:177434375
AGAAspartylglucosaminuriaLikely benign
(Apr 6, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr4:178355637
GRCh38:
Chr4:177434483
AGAAspartylglucosaminuriaUncertain significance
(Mar 19, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr4:178361536
GRCh38:
Chr4:177440382
AGAE58*AspartylglucosaminuriaPathogenic
(Mar 12, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr4:178363475
GRCh38:
Chr4:177442321
AGA, AGA-DTA19fsAspartylglucosaminuriaPathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr4:178361429
GRCh38:
Chr4:177440275
AGAD93EAspartylglucosaminuriaUncertain significance
(Mar 13, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr4:178363515
GRCh38:
Chr4:177442361
AGAAspartylglucosaminuriaLikely benign
(Feb 11, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr4:178352896
GRCh38:
Chr4:177431742
AGAN336fs, N326fsAspartylglucosaminuriaUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr4:178354373
GRCh38:
Chr4:177433219
AGAS302N, S312NAspartylglucosaminuriaUncertain significance
(Jan 13, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr4:178361428
GRCh38:
Chr4:177440274
AGAG94RAspartylglucosaminuriaUncertain significance
(Mar 9, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr4:178360818
GRCh38:
Chr4:177439664
AGAAspartylglucosaminuriaLikely benign
(Dec 29, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr4:178354348
GRCh38:
Chr4:177433194
AGAAspartylglucosaminuriaLikely benign
(Jun 27, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr4:178359952
GRCh38:
Chr4:177438798
AGAQ152KAspartylglucosaminuriaUncertain significance
(Jun 23, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr4:178359925
GRCh38:
Chr4:177438771
AGAR161WInborn genetic diseases, AspartylglucosaminuriaUncertain significance
(Oct 9, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr4:178360834
GRCh38:
Chr4:177439680
AGAM97TAspartylglucosaminuriaUncertain significance
(Jun 22, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr4:178358647
GRCh38:
Chr4:177437493
AGAAspartylglucosaminuriaLikely benign
(Dec 23, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr4:178361432
GRCh38:
Chr4:177440278
AGAM92IAspartylglucosaminuriaUncertain significance
(Jul 18, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr4:178355641
GRCh38:
Chr4:177434487
AGAR234HAspartylglucosaminuriaUncertain significance
(Jul 2, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr4:178361511
GRCh38:
Chr4:177440357
AGAR66TAspartylglucosaminuriaUncertain significance
(Jul 9, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr4:178358638
GRCh38:
Chr4:177437484
AGAAspartylglucosaminuriaLikely benign
(Oct 20, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr4:178361468
GRCh38:
Chr4:177440314
AGAAspartylglucosaminuriaLikely benign
(Sep 19, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr4:178357463
GRCh38:
Chr4:177436309
AGAT222fsAspartylglucosaminuriaPathogenic
(Sep 10, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr4:178355631
GRCh38:
Chr4:177434477
AGAAspartylglucosaminuriaLikely benign
(Aug 25, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr4:178358687
GRCh38:
Chr4:177437533
AGAAspartylglucosaminuriaLikely benign
(Aug 30, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr4:178363451
GRCh38:
Chr4:177442297
AGAAspartylglucosaminuriaLikely benign
(Jul 10, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr4:178363521
GRCh38:
Chr4:177442367
AGA-DT, AGAK4fsAspartylglucosaminuriaPathogenic
(Nov 27, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr4:178360004
GRCh38:
Chr4:177438850
AGAAspartylglucosaminuriaLikely benign
(Nov 27, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr4:178360721
GRCh38:
Chr4:177439567
AGAAspartylglucosaminuriaLikely benign
(Nov 1, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr4:178355566
GRCh38:
Chr4:177434412
AGAN249I, N259IAspartylglucosaminuriaUncertain significance
(Sep 6, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr4:178361465
GRCh38:
Chr4:177440311
AGAE81DAspartylglucosaminuriaUncertain significance
(Jun 13, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr4:178358641
GRCh38:
Chr4:177437487
AGAAspartylglucosaminuriaLikely benign
(May 27, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr4:178354434
GRCh38:
Chr4:177433280
AGAR282G, R292GAspartylglucosaminuriaUncertain significance
(Sep 17, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr4:178359879
GRCh38:
Chr4:177438725
AGAAspartylglucosaminuriaLikely benign
(Apr 24, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr4:178358629
GRCh38:
Chr4:177437475
AGAAspartylglucosaminuriaLikely benign
(Oct 8, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr4:178357509
GRCh38:
Chr4:177436355
AGAAspartylglucosaminuriaLikely benign
(Sep 23, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr4:178363484
GRCh38:
Chr4:177442330
AGA, AGA-DTL16FAspartylglucosaminuriaUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr4:178360746-178360749
GRCh38:
Chr4:177439592-177439595
AGAAspartylglucosaminuriaPathogenic
(Aug 22, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr4:178361414-178361415
GRCh38:
Chr4:177440260-177440261
AGAAspartylglucosaminuriaUncertain significance
(Apr 19, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr4:178358680
GRCh38:
Chr4:177437526
AGAAspartylglucosaminuriaLikely benign
(Sep 15, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr4:178354443
GRCh38:
Chr4:177433289
AGAV279M, V289MAspartylglucosaminuriaUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr4:178361470
GRCh38:
Chr4:177440316
AGAD80HAspartylglucosaminuriaUncertain significance
(May 27, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr4:178361549
GRCh38:
Chr4:177440395
AGAAspartylglucosaminuriaLikely benign
(Sep 28, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr4:178361573
GRCh38:
Chr4:177440419
AGAAspartylglucosaminuriaLikely benign
(Jul 31, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr4:178363426
GRCh38:
Chr4:177442272
AGA-DT, AGAP35LAspartylglucosaminuriaUncertain significance
(Jun 13, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr4:178361412
GRCh38:
Chr4:177440258
AGAAspartylglucosaminuriaLikely benign
(Apr 26, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr4:178357508
GRCh38:
Chr4:177436354
AGAAspartylglucosaminuriaUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr4:178361580
GRCh38:
Chr4:177440426
AGAA43VAspartylglucosaminuriaUncertain significance
(Mar 13, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr4:178354504
GRCh38:
Chr4:177433350
AGAAspartylglucosaminuriaUncertain significance
(Jul 11, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr4:178354498
GRCh38:
Chr4:177433344
AGAAspartylglucosaminuriaLikely benign
(Sep 16, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr4:178352885
GRCh38:
Chr4:177431731
AGAE330*, E340*AspartylglucosaminuriaPathogenic
(Sep 1, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr4:178354385
GRCh38:
Chr4:177433231
AGAN298S, N308SAspartylglucosaminuria, not provided, Inborn genetic diseases
Uncertain significance
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr4:178360786
GRCh38:
Chr4:177439632
AGAG113DAspartylglucosaminuriaUncertain significance
(Aug 6, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr4:178363390
GRCh38:
Chr4:177442236
AGA, AGA-DTAspartylglucosaminuriaLikely benign
(Aug 24, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr4:178358691
GRCh38:
Chr4:177437537
AGAAspartylglucosaminuriaLikely benign
(Jun 18, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr4:178358671
GRCh38:
Chr4:177437517
AGAAspartylglucosaminuriaLikely benign
(Mar 18, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr4:178354359
GRCh38:
Chr4:177433205
AGAAspartylglucosaminuriaLikely benign
(Sep 28, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination